ClinicalTrials.govpublic full text
Safety Study of Ivacaftor in Subjects With Cystic Fibrosis
cystic fibrosis, g551d mutation, fibrosis, pancreatic diseases, digestive system diseases, lung diseases, respiratory tract diseases, genetic diseases, inborn, infant, newborn, diseases, pathologic processes, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 912617
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.